Efficient small interfering RNA (siRNA) delivery into cells is the basis of target gene specific silencing and, ultimately, gene therapy. However, current transfection reagents are relatively inefficient and very few studies provide the sort of systematic understanding based on structure-activity relationships that would provide rationales for their improvement. This work establishes peptide dendrimers (administered with cationic lipids) as siRNA transfection reagents and records structure-activity relationships that highlight the importance of positive charge distributed in the two outer layers and a hydrophobic core as key features for efficient performance. These transfection reagents work as well as highly optimized commercial reagents, yet show less toxicity and fewer off-target effects. More generally, the degrees of freedom in the synthetic procedure will allow the placing of decisive recognition features to enhance and fine-tune transfection and cell specificity.
manipulate the observed effects are rare, emerging sometimes from polydisperse systems [4c] , but mainly from analysis of monodisperse reagents [2b, 11a, 12] ." 2.-Page 1, column 1, line 37-38: the definition of the abbreviation siRNA should be moved to line 30, first time it is mentioned.
Changed.
3.-Page 2, column 1, line 30: RL should be KL, I gather.
We could not locate this suggested correction. If the sentence "The best candidates, G2,3-KL and G2,3-RL exhibited 70% and 65% gene knock down, respectively." is meant, this statement is correct (see Table 1 -here residual GAPDH activity is quoted as the corresponding 30% and 35%.
4.-Page 3, column 2, line 2: strong uptake can be (remove , which). Line 44: that it is (remove the).
5. Note that the references format does not fit ChemBioChem's style and that some journal names are not properly abbreviated (e.g. Angewandte Chemie) Changed.
Reviewer 2 1.While the manuscript is generally well written, the discussion is a bit hard to follow. The authors jump directly into the biological results (figure 2) first followed by the biophysical evaluations in fig 4. As a result, the authors start with figure 2A and B, then jump to fig 4 and then come back to figures 2E and F. A number of times, the results and analysis and discussions are intertwined which make the narrative not as intuitive. Why not discuss biophysical properties first, followed by cell uptake and finally the biological results?
We have taken up the suggestion of the reviewer and changed the text to show first the most important biological data and then the biophysical properties that give inside into the possible mode of action of the dendrimers. Accordingly the data were rearranged, leading to the splitting up of one figure.
2. What is DOTMA and DOPE -this should be clarified at first mention in manuscript.
3. In general, the transfection agents do not outperform the gold standard lipofectamine 2000 from the literature. The authors claim that their formulation is less toxic based on minimal data showing greater knockdown of a control gene with L2000. That bit of data is not very convincing and the formulation does not cause off-target effects (it is toxic to cells) but the siRNA does. It just as likely that the enhanced activity with L2000 (80% knockdown versus 70% knockdown with G2,3KL) is responsible for these "off-target" effects.
We agree with the reviewer that the differences in cytotoxicity are small, but we still show that they are significant: our conclusion is based on sextuplicate experiments which were repeated 3-times, with the statistical analysis indicating significance. It is possible that the "off-target" effects are responsible for this, because the cell viability in Fig. 2B was measured after transfection.
We have added this idea to the text (p. 2, l. 24-29/right): "Apparently a non-specific interference effect is observed …. and possibly causing the observed greater cytotoxicity (compared to G2,3-KL and G2,3-RL)" 4.Why did the authors not compare the best dendrimer to L2000 in a dose-response to really characterize the differences in potency.
We have now added data on optimisation the best L2000 formulation (Supplementary Figure S3) . We have chosen the best L2000 formulation to compare with our PD formulation for the gene knockdown efficacy.
Similarly, why wasn't L2000 used a control for the cell uptake and biophysical studies.
We have now included cell uptake and biophysical data of L2000 in supplementary Figures S3 and S4.
5.Introduction -what is an siRNA with 2'-overhangs? Sorry -we meant 3'-overhangs (now also highlighted in the SI in 'Experimental procedures', p. S13).
6.Introduction -the LNP platform being used for siRNA delivery in the clinic is the clear front-runner
We have added two references to highlight how advanced these formulations are. (p. 4, l. 19-22 Abstract: Efficient small interfering RNA (siRNA) delivery into cells is the basis of target gene specific silencing and, ultimately, gene therapy. However, current transfection reagents are relatively inefficient and very few studies provide the sort of systematic understanding based on structure-activity relationships that would provide rationales for their improvement. This work establishes peptide dendrimers (administered with cationic lipids) as siRNA transfection reagents and records structure-activity relationships that highlight the importance of positive charge distributed in the two outer layers and a hydrophobic core as key features for efficient performance. These transfection reagents work as well as highly optimized commercial reagents, yet show less toxicity and fewer offtarget effects. More generally, the degrees of freedom in the synthetic procedure will allow the placing of decisive recognition features to enhance and fine-tune transfection and cell specificity. Cationic lipids [2a, 3] , polymers [4] dendrimers [5] , dendrimer-like structures [5g, 6] , peptides [7] , nanocarriers [8] , nanoparticles [9] nanocapsules [10] and supramolecular complexes [11] are examples of carrier vehicles that transport siRNA into cells.
However, efficiency, toxicity and stability in serum need to be further improved. Furthermore, in many cases the molecular basis of the observed effects is hard to delineate. Structureactivity relationships that would provide means to rationally manipulate the observed effects are rare, emerging sometimes from polydisperse systems [4c] , but mainly from analysis of monodisperse reagents [2b, 11a, 12] .
Peptide dendrimers (PDs) [13] are a new class of monodisperse transfection reagents, but have so far only been used for the transfection of plasmid DNA [12c] . They have been shown to be efficient DNA transfection reagents and obeyed systematic structure-activity relationships [12c] . A key determinant of efficiency was shown to be the location of cationic charges across three dendrimer generations, a feature that had not been accessible in other transfection reagents (see Figs. 1 and S1, SI for the structural formulae). Double stranded siRNA is more compact than DNA and acts in the cytosol rather than in the nucleus. Therefore efficient reagents for plasmid delivery are not necessarily active in siRNA transfection. [14] We now show that members of the same group of PDs originally shown to be active on DNA also transfect RNA. However, variation of the amino acid building blocks throughout the dendrimer suggests that transfection is governed by different rules for RNA vs DNA.
Thus, a library of third generation PDs [12c] displaying lysine (K) or arginine (R) as cationic residues and leucine or alanine as a hydrophobic moieties and dimerized KL (=LysLeu) dendrimers (shown in Table 1 ; see the SI for detailed synthetic procedures and characterization of the PDs) was tested in a gene knock-out assay. Table 1 shows the 14 structures of the PDs tested, which are referred to in the text by abbreviations that highlight the pattern in the dendrimer generational layers (e.g. G2,3-KL has the motif KL in generation 2 and 3 and LL in generation 1; see Figure 1 ).
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The success of siRNA transfection was measured by experiments in which HeLa cells were treated with an siRNA designed to target the enzyme GAPDH (siGAPDH) [14] and a combination of the PDs (at an N/P ratio of 10) with cationic lipid/ neutral helper lipid DOTMA/DOPE (DOTMA: 1,2-dioleyloxy-3-trimethylammonium propane chloride, DOPE: 1,2-dioleoylglycero-3-phosphatidylethanolamine; administered in a w/w ratio of 2:1 to siRNA). The transfection efficiency was quantified by monitoring the decrease in GAPDH enzyme activity (evaluated with a fluorescence assay). [14] To rule out that gene silencing is due to a non-specific effect, a validated siRNA (siNC) was used as a control (see SI). All fourteen PDs showed (when administered in combination with DOTMA/DOPE) some degree of transfection. None of them showed activity in the absence of the cationic lipids (SI Figure S2 ). The best candidates, G2,3-KL and G2,3-RL exhibited 70% and 65% gene knock down,
respectively. This represents significant gene silencing when compared to the DOTMA/DOPE-siRNA complex (p<0.05) and also to untreated cells (being comparable to the highly optimized commercial reagent L2000; Figure 2A ). L2000, however, suffers from strong off-target effects: we observed 35% GAPDH knockdown even when using a non-specific siRNA (siNC, see SI Figure S3 ), where no knock-down of GAPDH should be observed. Apparently a non-specific interference effect is observed for L2000-siRNA, affecting the expression pattern of a number of genes [15] and possibly causing the observed greater cytotoxicity (compared to G2,3-KL and G2,3-RL). In particular for molecular therapy approaches the imprecision caused by such non-specific effects would be detrimental and the avoidance of off-target activity gives PDs an advantage.
The physically associated dendriplexes were prepared by simply mixing dendrimer with DOTMA/DOPE and siRNA (see the SI for a typical experimental procedure This observation suggests that the globular dendritic structure is beneficial, possibly by providing better encapsulation or protection to facilitate cellular siRNA uptake (Figures 3 and 4) , when compared to the more rigid linear lysines, which are not as effective. [16] At the same time PD/lipid combinations showed low or barely measurable toxicity, as determined by crystal violet viability assays ( Figure 2B ).
A clear trend was identified by comparison of dendrimers with the same amino acid composition, but different structural arrangements of these same amino acids in the dendrimer: the best transfection reagents have hydrophobic residues in the first generation and alternating hydrophobic/charged residues in the second and third generations, which induced significant gene silencing compared to all other PD complexes, DOTMA/DOPE, the respective siNC and untreated cell controls (p<0.05) (e.g.
G2,3-KL or G2,3-RL). The correlation of transfection efficiency
with the alternating pattern is independent of the type of charged residue (e.g. G2,3-KL or G2,3-RL). These rules differ from those derived for DNA transfection: spreading the charge throughout the dendrimer contributed to efficient transfection of DNA, while concentration of charges at the surface seemed to be more important for siRNA. Increasing the size of the dendrimers by dimerization tended to be detrimental to activity for siRNA (e.g.
G2,3,-KL vs [G2,3,-KL]2), but was enhancing DNA transfection.
[12c] The charge density (molecular weight to charge ratio) of PDs had been shown to be important in governing DNA delivery [12c] while there is no such correlation for siRNA. This difference suggests that the delivery of siRNA depends on physical dendrimer characteristics that remain to be specified.
CD spectroscopy showed that the more active G2,3-KL, G2,3-RL, G1,2,3-KL and G1,2,3-RL differ from the more hydrophobic G3-KL and G3-RL in their conformation in solution (Fig. 3A) , while diffusion 1H NMR indicated that the less active G3-KL and G3-RL are less compact than the active dendrimers (Table 2) .
Dynamic light scattering measurements demonstrated that the KL, RL series form smaller siRNA complexes with increased charges and more compact complexes than DOTMA/DOPE alone (Fig. 3B ). These empirical correlations indicate structural effects, even though they may not necessarily be the direct cause of variations in gene silencing efficiency. For the KL series, G1,2,3-KL clearly showed lower cell uptake, whereas G3-KL and G2,3-KL gave similar RFU signals. The same trend was observed for their corresponding homodimers (Fig. S4 SI) . The RL PDs also showed a similar pattern for the three different dendrimer scaffolds, in which the overall fluorescence signal for the individual complexes was stronger compared to the analogous KL compounds, suggesting better uptake into HeLa cells. Overall, the observation that G1,2,3-KL and G1,2,3-RL did not show strong uptake can be explained by the weaker siRNA binding. The observation that G3-KL and G3-RL did not show better transfection can be rationalized by their weak siRNA dissociation, i.e. an inability to set their cargo free.
The analogues, in which leucine was replaced by alanine (G1,2,3-KA) or histidine (G1,2,3-KH), gave similar Cy3 signals, indicating that the nature of the hydrophobic residue does not influence the transfection ability of the complexes. The uptake of the lipid-dendrimer-siRNA complexes evidently correlates with the transfection efficiency (see Figure S4 , SI, for the remaining dendrimers and controls).
Taken together the results indicate that the interplay of charged and hydrophobic residues is necessary for efficient transfection:
the PD with lysine residues in the branches only (and consequently the highest total charge) is the least effective reagent. The same observation was made with the linear sequences K24 and K32, both not performing well in transfection assay. Placing positive charges only on the peripheral layer is also not sufficient for efficiency. There is a subtle balance between the number of positive charges, the nature of the cationic residue and the distribution of charges through the dendritic structure that jointly determine the efficiency of a transfection reagent (when administered with DOTMA/DOPE).
The right combination is achieved in the dendrimers G2,3-KL and G2,3-RL, which also appear to provide a less compact conformation in solution that favors complexation, a unique property of the dendritic nature of this new transfection reagents.
Overall the activity of dendrimers with lysine and arginine are similar: G2,3-KL and G2,3-RL are the most active PDs (70% and 65 % GAPDH activity silencing respectively, Table 1 ). Changing the hydrophobic residue from leucine to alanine or histidine in the PDs did not influence the GAPDH activity substantially, consistent with the idea that it is the pattern of hydrophobic and cationic residues rather than a specific feature of the dendritic   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 structure that plays an important role in the transfection ability of dendrimers.
PDs with a branched and flexible architecture are well suited to form stable complexes with short and rigid siRNA molecules.
The requirement for flexibility has already been highlighted for the related polyamidoamine dendrimers (PAMAM), which are too rigid for efficient binding and delivery. Degraded PAMAM dendrimers were shown to be more suitable transfection agents [17] and our work provides a possible explanation, by
showing that structures with greater flexibility can be more effective. However, in other systems (such as triazine dendrimers) rigid structures were more effective. This discrepancy could be due to the very different chemical composition and the resulting intrinsic properties of the scaffold that influences siRNA binding. [5c, 18] These guidelines could be drawn up only because -in contrast to the overwhelming majority of transfection reagents described previously -systematic variation of PD structure was possible and gave rise to structure-function relationships. While clinical use (as for the much more advanced lipid nanoparticles [19] ) remains so far just a long-term ambition, PDs join the arsenal of siRNA delivery reagents as a new class in which exploration of chemical diversity can help rationalize efficiency gains to provide a framework for the design of effective and safe transfection reagents in the future. Well-defined PD structures are easily synthesized by solid phase peptide synthesis (SPPS) from natural or unnatural amino acids, [20] which will make this new class of RNA transfection reagents readily accessible.
Experimental Section
Synthesis. The peptide dendrimers were prepared by solid phase peptide Statistical analysis. The data presented in this study was analyzed using a two-tailed, unpaired Student t-test and one-way or two way ANOVA followed by a post-hoc test when appropriate.
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